By Patrick Lane
LP(a) and Cholesterol Numbers
You probably know your cholesterol numbers, or at least recognize them on a lab report. Total cholesterol, LDL, HDL, and triglycerides have been part of routine conversations about heart health.
However, there is another number receiving more attention lately. One such number is LP(a). Many people who follow cholesterol closely have never heard of it.
It’s called lipoprotein(a), usually shortened to LP(a). One of the most interesting facts is that you can do many healthy things and still have a high level. Additionally, you can exercise regularly, eat thoughtfully, maintain a healthy weight and have respectable cholesterol numbers. Moreover, it follows different rules because the amount in blood is largely determined by the genes you inherited.
That doesn’t mean a high Lp(a) is a reason to panic. It does mean this once relatively obscure blood marker is becoming an important part of the conversation about cardiovascular risk.
In March 2026, the American Heart Association and American College of Cardiology released updated guidelines on managing cholesterol and other blood lipids. Among the notable changes was a recommendation that Lp(a) be measured at least once in a person’s lifetime. Because levels are predominantly genetically determined and tend to remain relatively stable, one measurement is generally enough to identify someone with an elevated level, although certain health conditions and life changes can affect results.
So what exactly is Lp(a)?
To understand it, start with LDL, the cholesterol carrier most of us know as “bad cholesterol.” Lp(a) is a particle that resembles LDL but has an additional protein attached to it called apolipoprotein(a). That extra component changes the way the particle behaves and appears to contribute to cardiovascular risk.
Elevated Lp(a) has been associated with atherosclerotic cardiovascular disease, which includes heart attack and stroke, as well as calcific aortic valve disease. The European Atherosclerosis Society concluded after reviewing extensive genetic and population research that the evidence supports Lp(a) as a causal cardiovascular risk factor rather than simply something that happens to be present in people who develop heart disease.
This is where Lp(a) becomes particularly interesting. Someone may have LDL cholesterol that doesn’t raise immediate concern yet still have another inherited source of cardiovascular risk that wouldn’t necessarily appear on a standard cholesterol panel.
And unless someone specifically tests for Lp(a), they may never know.
The Genetic Connection
Unlike many familiar cardiovascular risk factors, Lp(a) is largely inherited. Diet and exercise are tremendously important for overall cardiovascular health, but they generally don’t have much effect on the Lp(a) number itself. That distinction matters because a person shouldn’t interpret an elevated result as evidence that they’ve done something wrong. It isn’t a report card on how well you’ve eaten or how many workouts you’ve completed. In many cases, it is simply part of the genetic hand you were dealt.
It also explains why family history matters. When heart attacks, strokes or other cardiovascular problems have occurred unexpectedly or relatively early in a family, physicians may look beyond the traditional risk factors for additional clues. An inherited elevation in Lp(a) can sometimes be one piece of that puzzle.
Because Lp(a) runs in families, learning that one person has a markedly elevated level may also lead to conversations with a healthcare professional about whether relatives should be evaluated.
Why Haven’t We Heard More About It?
This is probably the question many will have. If Lp(a) matters, why haven’t doctors routinely discussed it for decades? Part of the answer is that cardiovascular medicine continues to evolve. Researchers have known about Lp(a) for many years, but understanding of its role in cardiovascular disease has grown considerably. Another practical issue has been that, unlike LDL cholesterol, there historically hasn’t been a widely available treatment used specifically to lower Lp(a) with proven cardiovascular benefit. That created an unusual situation. Why routinely measure something if there was little doctors could do specifically about the number? Thinking around that question has changed.
Knowing about an elevated Lp(a) can provide additional information about someone’s overall cardiovascular risk. Rather than looking at one laboratory value in isolation, physicians can consider Lp(a) alongside cholesterol, blood pressure, smoking history, diabetes, family history and other relevant factors.
Think of it less as a diagnosis and more as another piece of information. A high number doesn’t mean someone is destined to develop heart disease, just as a lower number doesn’t guarantee that they won’t. Cardiovascular risk is much more complicated than any single blood test.
What Does a Result Mean?
This is one area where an internet search can create unnecessary confusion. Lp(a) can be reported in different units, most commonly milligrams per deciliter (mg/dL) or nanomoles per liter (nmol/L). Those units measure somewhat different characteristics of the particle and aren’t reliably converted with one simple mathematical formula.
The European Atherosclerosis Society has described less than 30 mg/dL, or 75 nmol/L, as a lower-risk range and 50 mg/dL, or 125 nmol/L, and above as a level that can increase cardiovascular risk, with a gray zone in between. But a laboratory number shouldn’t be interpreted in isolation. Its significance depends on the rest of a person’s cardiovascular picture. That is one reason this isn’t a test to diagnose yourself with after seeing a result in an online patient portal. A physician can put the number into context with the rest of your health history.
There is another useful feature of Lp(a) testing: fasting generally isn’t required. And because levels are primarily genetic and usually fairly stable, it isn’t necessarily another number that needs to be chased every few months.
If Lifestyle Doesn’t Lower It, Why Know?
This is perhaps the most important question of all. If someone learns that their Lp(a) is elevated and can’t simply lower it by eating more vegetables or walking another mile, wouldn’t knowing create unnecessary worry? Not necessarily.
Cardiovascular health is made up of multiple factors. While someone may not be able to change the genes influencing Lp(a), a healthcare professional can use that information when considering the person’s overall cardiovascular risk and other factors that may be modifiable.
The goal isn’t to become obsessed with one number. It’s to have a clearer picture. This distinction is especially important because healthy habits still matter enormously. Exercise, nutritious food, avoiding tobacco, maintaining appropriate blood pressure and addressing other cardiovascular risk factors remain important even though those behaviors may not significantly change the Lp(a) measurement itself.
In other words, “I can’t change my Lp(a)” and “there’s nothing I can do for my heart health” are two very different statements.
What About Treatments?
This is an especially interesting area of research. Scientists are studying medications designed specifically to dramatically reduce Lp(a), including therapies that interfere with the body’s production of apolipoprotein(a). Several have advanced through clinical development, but lowering a laboratory value isn’t the only goal. Researchers need to establish whether reducing Lp(a) actually translates into fewer heart attacks, strokes and other cardiovascular events.
Those studies are important because medicine has learned repeatedly that improving a biomarker doesn’t automatically guarantee better health outcomes. For now, treatment decisions for someone with elevated Lp(a) depend on the person’s broader cardiovascular picture and belong in a conversation with a qualified healthcare professional. This is also an area likely to change as new clinical-trial results become available.
One Number, Not the Whole Story
Perhaps the best way to understand Lp(a) is to resist making it either more frightening or less important than it deserves to be. Heart health has never been determined by one number. Not cholesterol. Not blood pressure. Not a calcium score. And not Lp(a).
What Lp(a) offers is another window into risk, particularly a portion of risk that may have been inherited rather than acquired through lifestyle. For someone who has spent years carefully watching cholesterol, discovering that another cholesterol-related particle exists may initially feel frustrating. But more information doesn’t have to mean more fear. Sometimes it simply means asking a better question.
The next time you’re discussing cholesterol or cardiovascular health with your healthcare provider, Lp(a) may be worth including in the conversation, particularly now that major cardiovascular guidelines recommend measuring it at least once during a lifetime. Your provider can determine whether testing makes sense in your individual circumstances and, if you already have a result, explain what that number means alongside the rest of your health information.
For years, most of us learned that knowing our cholesterol was part of understanding our heart health. Medicine now knows the picture is a little more detailed than that. Lp(a) may be only one piece of the puzzle, but for some people, it could be a piece worth knowing about.
